Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Genitourinary 1Dermatologic 1Breast 1

Conditions

Breast Neoplasms 50Triple Negative Breast Neoplasms 41Carcinoma, Non-Small-Cell Lung 11Head and Neck Neoplasms 8Carcinoma, Renal Cell 8Ovarian Neoplasms 7Melanoma 6Carcinoma, Hepatocellular 6Pancreatic Neoplasms 5Neoplasms 5Neoplasm Metastasis 5Colorectal Neoplasms 5Carcinoma, Transitional Cell 5Uterine Cervical Neoplasms 4Stomach Neoplasms 4Small Cell Lung Carcinoma 4Urinary Bladder Neoplasms 3Sarcoma 3Prostatic Neoplasms 3Gastrointestinal Neoplasms 3Endometrial Neoplasms 3Carcinoma, Merkel Cell 3Urogenital Neoplasms 2Lymphoma 2Lung Neoplasms 2Kidney Neoplasms 2HER2-positive Breast Cancer 2Esophageal Neoplasms 2Vulvar Neoplasms 1Urologic Neoplasms 1

Interventions

atezolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Urologic Diseases × atezolizumab × Breast × Clear all
NCT02543645 2018-04-30

A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer

Celldex Therapeutics

Phase 1 Terminated
18 enrolled
BreastDermatologicGenitourinaryHead & NeckThoracic

Clear-cell metastatic renal cell carcinoma, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Head and Neck Neoplasms, Kidney Diseases, Kidney Neoplasms, Melanoma, Neoplasms, Neoplasms by Histologic Type, Urogenital Neoplasms, Urologic Diseases, Urologic Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡